On November 4, 2020 Jubilant Therapeutics Inc., a biopharmaceutical company advancing small molecule modulators to address unmet medical needs in oncology and autoimmune diseases, reported that Company management will participate in three upcoming investor conferences (Press release, Jubilant Therapeutics, NOV 4, 2020, View Source [SID1234569912]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

– The Credit Suisse 29th Annual Healthcare Conference taking place November 9-12. Jubilant Therapeutics will present virtually on Wednesday, November 11 at 8:00 a.m. Eastern Time (ET). Click Here to register and attend.

– The LSX Investival Showcase taking place November 11-16. Jubilant Therapeutics will share a company presentation virtually during this event that would be available on the event portal. Click Here to register and attend.

– The Jefferies 2020 Virtual London Healthcare Conference taking place November 17-19. Jubilant Therapeutics will virtually attend this conference and will be available for meetings. Click Here to register and attend.